Copyright
©The Author(s) 2025.
World J Crit Care Med. Jun 9, 2025; 14(2): 100844
Published online Jun 9, 2025. doi: 10.5492/wjccm.v14.i2.100844
Published online Jun 9, 2025. doi: 10.5492/wjccm.v14.i2.100844
Figure 2 Epidemiology and patient characteristics.
A: Trends in cannabis use among hospitalized cancer patients with severe sepsis. This line graph displays the proportion of patients receiving vasopressors during their hospitalization over a five-year period. Trends are shown for the total patient population, as well as for males and females separately; B: Comparison of comorbidities between cannabis use disorder (CUD) (+) and CUD(-) cohorts, expressed as percentages. This figure displays the percentage of patients with various comorbidities in the two cohorts: Those with and without CUD. HLD: Hypomyelinating leukodystrophy.
- Citation: Sager AR, Desai R, Mylavarapu M, Shastri D, Devaprasad N, Thiagarajan SN, Chandramohan D, Agrawal A, Gada U, Jain A. Cannabis use disorder and severe sepsis outcomes in cancer patients: Insights from a national inpatient sample. World J Crit Care Med 2025; 14(2): 100844
- URL: https://www.wjgnet.com/2220-3141/full/v14/i2/100844.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i2.100844